Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
Crossref DOI link: https://doi.org/10.1007/s13300-020-00955-2
Published Online: 2020-11-08
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ma, Jianhua
Zhang, Bin
Hou, Jianing
Peng, Yongde
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2020-11-08
Version of Record valid from 2020-11-08
Article History
Received: 11 August 2020
Accepted: 21 October 2020
First Online: 8 November 2020